RUFINAMIDE

RUFINAMIDE was reported 2630 times

RUFINAMIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 JEAVONS SYNDROME 2 0.4000
1 MICRODONTIA 1 0.2500
2 ATYPICAL ABSENCE SEIZURE 1 0.2500
3 GENERALISED ONSET NON-MOTOR SEIZURE 7 0.2121
4 ECHOCARDIOGRAM NORMAL 1 0.1667
5 DERMATOPHAGIA 1 0.1250
6 CORNELIA DE LANGE SYNDROME 1 0.0909
7 LENNOX-GASTAUT SYNDROME 18 0.0793
8 ATONIC SEIZURES 60 0.0698
9 GELASTIC SEIZURE 2 0.0690
10 MEDICAL DEVICE ADJUSTMENT 1 0.0625
11 EPILEPTIC ENCEPHALOPATHY 13 0.0583
12 VAGAL NERVE STIMULATOR IMPLANTATION 17 0.0556
13 CSWS SYNDROME 1 0.0435
14 SEIZURE CLUSTER 33 0.0398
15 CORTICAL VISUAL IMPAIRMENT 2 0.0345
16 BENZODIAZEPINE DRUG LEVEL 1 0.0333
17 MULTIPLE-DRUG RESISTANCE 102 0.0329
18 GASTROSTOMY FAILURE 1 0.0323
19 FEBRILE INFECTION-RELATED EPILEPSY SYNDROME 1 0.0323
20 HYPOCITRATURIA 2 0.0308
21 TONIC CONVULSION 43 0.0303
22 SUDDEN UNEXPLAINED DEATH IN EPILEPSY 16 0.0299
23 MEDICAL DEVICE BATTERY REPLACEMENT 4 0.0296
24 POSTICTAL PARALYSIS 7 0.0289
25 BACTERIAL TRACHEITIS 2 0.0247
26 SELECTIVE MUTISM 2 0.0238
27 NEURODEVELOPMENTAL DELAY 1 0.0217
28 CHANGE IN SEIZURE PRESENTATION 14 0.0216
29 MYOCLONIC EPILEPSY 31 0.0204
30 MITRAL VALVE THICKENING 6 0.0201
31 GASTRIC ATONY 1 0.0185
32 MYRINGOTOMY 1 0.0185
33 MEDICAL DEVICE SITE CELLULITIS 1 0.0172
34 INTRA-UTERINE CONTRACEPTIVE DEVICE INSERTION 1 0.0161
35 CHEST CRUSHING 1 0.0156
36 MEDICAL DEVICE SITE ABSCESS 1 0.0145
37 NEUROPROSTHESIS IMPLANTATION 2 0.0144
38 PINEAL GLAND CYST 2 0.0143
39 NON-24-HOUR SLEEP-WAKE DISORDER 2 0.0142
40 ANGIOFIBROMA 1 0.0135
41 CARDIAC STEATOSIS 1 0.0135
42 PARTIAL SEIZURES WITH SECONDARY GENERALISATION 6 0.0128
43 FEEDING DISORDER OF INFANCY OR EARLY CHILDHOOD 2 0.0122
44 DOLICHOCOLON 1 0.0122
45 DRUG METABOLITE LEVEL HIGH 1 0.0119
46 INTELLECTUAL DISABILITY 18 0.0118
47 PNEUMONIA PARAINFLUENZAE VIRAL 2 0.0118
48 ANTICONVULSANT DRUG LEVEL INCREASED 19 0.0118
49 PH URINE INCREASED 2 0.0116
50 BENZODIAZEPINE DRUG LEVEL INCREASED 1 0.0105
51 FRONTAL LOBE EPILEPSY 1 0.0103
52 BLINDNESS CORTICAL 5 0.0102
53 DRUG WITHDRAWAL CONVULSIONS 18 0.0101
54 MEDICAL DEVICE SITE INJURY 1 0.0101
55 NASAL TURBINATE ABNORMALITY 1 0.0095
56 FANCONI SYNDROME 13 0.0092
57 FOREIGN BODY INGESTION 1 0.0089
58 PETIT MAL EPILEPSY 45 0.0088
59 STOMA OBSTRUCTION 2 0.0087
60 OEDEMATOUS KIDNEY 2 0.0075
61 SIMPLE PARTIAL SEIZURES 6 0.0074
62 DEVELOPMENTAL REGRESSION 1 0.0074
63 COAGULATION FACTOR DECREASED 2 0.0073
64 GASTROINTESTINAL STOMA OUTPUT DECREASED 1 0.0071
65 AGONAL RESPIRATION 2 0.0071
66 HYPERACTIVE PHARYNGEAL REFLEX 1 0.0069
67 SELF-DESTRUCTIVE BEHAVIOUR 6 0.0069
68 BEHAVIOUR DISORDER 37 0.0068
69 IMPLANT SITE EROSION 2 0.0068
70 ACCELERATED IDIOVENTRICULAR RHYTHM 1 0.0068
71 DROP ATTACKS 4 0.0067
72 ELECTROCARDIOGRAM QT SHORTENED 2 0.0066
73 PATIENT UNCOOPERATIVE 3 0.0063
74 AORTIC VALVE THICKENING 1 0.0062
75 CALCULUS URINARY 9 0.0058
76 HEPATIC ADENOMA 3 0.0058
77 SEIZURE 670 0.0058
78 STATUS EPILEPTICUS 65 0.0057
79 GENERALISED TONIC-CLONIC SEIZURE 95 0.0057
80 NEAR DROWNING 1 0.0057
81 OPHTHALMOLOGICAL EXAMINATION ABNORMAL 1 0.0056
82 DISSOCIATIVE DISORDER 4 0.0055
83 COLOBOMA 1 0.0053
84 TRACHEITIS 4 0.0052
85 BIOPSY KIDNEY ABNORMAL 1 0.0051
86 TRICHOTILLOMANIA 3 0.0051
87 POVERTY OF SPEECH 2 0.0051
88 CARDIAC NEOPLASM UNSPECIFIED 1 0.0050
89 GASTROSTOMY TUBE SITE COMPLICATION 1 0.0050
90 VITAMIN K DEFICIENCY 2 0.0050
91 PECTUS EXCAVATUM 1 0.0049
92 EXCESSIVE MASTURBATION 1 0.0048
93 STUBBORNNESS 2 0.0046
94 STILLBIRTH 22 0.0045
95 AORTIC DILATATION 5 0.0045
96 PNEUMATOSIS 2 0.0045
97 FACIAL SPASM 5 0.0045
98 FEEDING INTOLERANCE 2 0.0044
99 ECHOCARDIOGRAM ABNORMAL 6 0.0043
100 MOOD DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0041
101 CLONIC CONVULSION 3 0.0041
102 ENTEROBACTER TEST POSITIVE 1 0.0041
103 HYPERDYNAMIC LEFT VENTRICLE 1 0.0041
104 ARTERIAL THERAPEUTIC PROCEDURE 1 0.0041
105 PARTIAL SEIZURES 21 0.0040
106 DELAYED PUBERTY 1 0.0039
107 GLOMERULONEPHROPATHY 1 0.0039
108 ERYTHEMA INFECTIOSUM 1 0.0039
109 EPILEPTIC AURA 1 0.0039
110 GASTROSTOMY 6 0.0039
111 BODY TEMPERATURE FLUCTUATION 8 0.0038
112 DEPOSIT EYE 1 0.0037
113 AMMONIA INCREASED 19 0.0037
114 EAR INFECTION BACTERIAL 1 0.0037
115 EXECUTIVE DYSFUNCTION 2 0.0037
116 MORAXELLA INFECTION 1 0.0036
117 GROIN INFECTION 2 0.0036
118 ONYCHOPHAGIA 1 0.0036
119 PRECOCIOUS PUBERTY 2 0.0035
120 ENTEROVIRUS INFECTION 3 0.0035
121 RIGHT VENTRICULAR DILATATION 2 0.0035
122 FANCONI SYNDROME ACQUIRED 6 0.0034
123 CEREBELLAR ATROPHY 3 0.0034
124 RIGHT VENTRICULAR HYPERTROPHY 3 0.0033
125 HYPERVIGILANCE 3 0.0031
126 DEFECT CONDUCTION INTRAVENTRICULAR 1 0.0031
127 MAGNETIC RESONANCE IMAGING HEAD ABNORMAL 2 0.0031
128 CENTRAL SLEEP APNOEA SYNDROME 1 0.0031
129 CATHETER SITE IRRITATION 1 0.0030
130 HYPERAMMONAEMIA 15 0.0030
131 DRUG RESISTANCE 77 0.0030
132 LARYNGOMALACIA 1 0.0030
133 DROWNING 3 0.0030
134 BRAIN MASS 1 0.0030
135 GLYCOSURIA 4 0.0030
136 PRODUCT SUPPLY ISSUE 21 0.0029
137 GAZE PALSY 5 0.0029
138 RHINOVIRUS INFECTION 11 0.0028
139 DRUG-GENETIC INTERACTION 1 0.0028
140 BRAIN MALFORMATION 1 0.0028
141 ATAXIA 33 0.0028
142 FEEDING TUBE USER 1 0.0027
143 EPILEPSY 83 0.0027
144 COMPLEX PARTIAL SEIZURES 3 0.0027
145 LID SULCUS DEEPENED 1 0.0027
146 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 2 0.0027
147 FOCAL DYSCOGNITIVE SEIZURES 3 0.0026
148 METAPNEUMOVIRUS INFECTION 2 0.0026
149 GROWTH HORMONE DEFICIENCY 1 0.0025
150 VITAMIN B12 INCREASED 2 0.0025
151 OROPHARYNGEAL PLAQUE 1 0.0025
152 ANHIDROSIS 1 0.0025
153 NYSTAGMUS 13 0.0024
154 HAND-FOOT-AND-MOUTH DISEASE 2 0.0024
155 CIRCADIAN RHYTHM SLEEP DISORDER 2 0.0024
156 GASTROINTESTINAL TUBE INSERTION 6 0.0024
157 TRICUSPID VALVE INCOMPETENCE 19 0.0024
158 HYPERAMMONAEMIC ENCEPHALOPATHY 4 0.0023
159 PRODUCT ADMINISTRATION INTERRUPTED 18 0.0023
160 FOOD REFUSAL 2 0.0023
161 MITOCHONDRIAL CYTOPATHY 1 0.0023
162 ELECTROENCEPHALOGRAM ABNORMAL 7 0.0022
163 ECZEMA HERPETICUM 1 0.0022
164 PULMONARY VALVE INCOMPETENCE 3 0.0021
165 EXCESSIVE EYE BLINKING 3 0.0020
166 HYPOHIDROSIS 1 0.0020
167 MOTOR DYSFUNCTION 20 0.0020
168 POSTICTAL STATE 2 0.0019
169 CONVULSION NEONATAL 1 0.0019
170 GRIEF REACTION 1 0.0019
171 EXPULSION OF MEDICATION 1 0.0019
172 HYPERKINESIA 4 0.0019
173 LEFT ATRIAL ENLARGEMENT 1 0.0019
174 BINGE EATING 2 0.0019
175 AUTOSCOPY 1 0.0019
176 OPTIC ATROPHY 3 0.0018
177 MEAN CELL HAEMOGLOBIN CONCENTRATION INCREASED 1 0.0018
178 DYSPRAXIA 1 0.0018
179 ENTERAL NUTRITION 1 0.0017
180 IRREGULAR BREATHING 1 0.0017
181 MITRAL VALVE INCOMPETENCE 19 0.0017
182 PRODUCT PREPARATION ISSUE 11 0.0017
183 GRUNTING 1 0.0017
184 DEEP BRAIN STIMULATION 1 0.0017
185 FEBRILE CONVULSION 2 0.0016
186 DERMATOSIS 1 0.0016
187 AGGRESSION 80 0.0016
188 DROOLING 11 0.0016
189 ABDOMINAL COMPARTMENT SYNDROME 1 0.0016
190 PNEUMONIA ASPIRATION 39 0.0016
191 TONIC CLONIC MOVEMENTS 2 0.0015
192 MITE ALLERGY 1 0.0015
193 AFFECTIVE DISORDER 12 0.0015
194 SALIVARY HYPERSECRETION 15 0.0015
195 COLITIS MICROSCOPIC 7 0.0015
196 PATIENT-DEVICE INCOMPATIBILITY 1 0.0015
197 NUTRITIONAL CONDITION ABNORMAL 1 0.0014
198 BRONCHIAL OBSTRUCTION 2 0.0014
199 DERMATITIS DIAPER 1 0.0014
200 AORTIC VALVE INCOMPETENCE 6 0.0014
201 TRACHEOSTOMY 2 0.0014
202 BITE 1 0.0014
203 DRUG LEVEL DECREASED 14 0.0014
204 OBSTRUCTIVE SLEEP APNOEA SYNDROME 2 0.0014
205 CYCLIC VOMITING SYNDROME 1 0.0014
206 AMPHETAMINES POSITIVE 1 0.0013
207 MICTURITION FREQUENCY DECREASED 1 0.0013
208 CONVULSION 76 0.0013
209 EMERGENCY CARE 4 0.0013
210 PARAINFLUENZAE VIRUS INFECTION 2 0.0013
211 BRAIN OPERATION 3 0.0013
212 INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION 1 0.0013
213 GASTROINTESTINAL SURGERY 1 0.0013
214 IMPLANT SITE EXTRAVASATION 1 0.0013
215 GASTROINTESTINAL STOMA COMPLICATION 2 0.0013
216 SEDATION 33 0.0013
217 OPISTHOTONUS 1 0.0013
218 MYOCLONUS 15 0.0013
219 PANCREATITIS RELAPSING 1 0.0012
220 NEONATAL HYPOXIA 1 0.0012
221 MITRAL VALVE PROLAPSE 2 0.0012
222 SLEEP TALKING 2 0.0012
223 INCREASED BRONCHIAL SECRETION 3 0.0012
224 CRANIOFACIAL FRACTURE 1 0.0012
225 RETINAL DISORDER 3 0.0012
226 DRUG LEVEL INCREASED 19 0.0011
227 PSYCHOMOTOR SKILLS IMPAIRED 3 0.0011
228 ALOPECIA AREATA 2 0.0011
229 BLOOD MAGNESIUM INCREASED 1 0.0011
230 SCREAMING 7 0.0011
231 ABULIA 1 0.0011
232 LOBAR PNEUMONIA 2 0.0011
233 AURA 2 0.0011
234 THERAPY NON-RESPONDER 48 0.0011
235 FACE INJURY 4 0.0011
236 CEREBRAL PALSY 1 0.0011
237 COMMUNICATION DISORDER 4 0.0010
238 ABNORMAL BEHAVIOUR 41 0.0010
239 RESPIRATORY SYNCYTIAL VIRUS INFECTION 9 0.0010
240 PRESCRIBED OVERDOSE 20 0.0010
241 CONVERSION DISORDER 2 0.0010
242 UNDERWEIGHT 2 0.0010
243 METABOLIC ENCEPHALOPATHY 3 0.0010
244 ARTHRODESIS 1 0.0010
245 GASTROINTESTINAL VIRAL INFECTION 1 0.0010
246 INTERVERTEBRAL DISC COMPRESSION 1 0.0010
247 CONSCIOUSNESS FLUCTUATING 1 0.0010
248 WALKING DISABILITY 2 0.0010
249 NEUROMYOPATHY 1 0.0009
250 LETHARGY 54 0.0009
251 LEFT VENTRICULAR HYPERTROPHY 4 0.0009
252 JAW FRACTURE 2 0.0009
253 SOMNOLENCE 186 0.0009
254 INFUSION SITE MASS 1 0.0009
255 COGNITIVE DISORDER 43 0.0009
256 KIDNEY ENLARGEMENT 1 0.0009
257 GASTROINTESTINAL TRACT IRRITATION 1 0.0009
258 CEREBELLAR SYNDROME 2 0.0009
259 HYPOTONIA 9 0.0009
260 MOANING 1 0.0009
261 GASTROINTESTINAL BACTERIAL INFECTION 1 0.0009
262 BLOODY DISCHARGE 1 0.0009
263 HYPERSOMNIA 25 0.0009
264 APLASIA PURE RED CELL 3 0.0009
265 INFUSION SITE INFECTION 2 0.0009
266 HYPORESPONSIVE TO STIMULI 1 0.0009
267 STARING 2 0.0008
268 WRONG DOSE 2 0.0008
269 ASPIRATION 9 0.0008
270 ACUTE PSYCHOSIS 2 0.0008
271 INFREQUENT BOWEL MOVEMENTS 2 0.0008
272 VENTRICULAR HYPERTROPHY 2 0.0008
273 HEPATIC INFECTION 1 0.0008
274 INCREASED UPPER AIRWAY SECRETION 4 0.0008
275 LIBIDO DISORDER 1 0.0008
276 LIP INJURY 1 0.0008
277 EXFOLIATIVE RASH 2 0.0008
278 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 13 0.0008
279 APPETITE DISORDER 5 0.0008
280 GASTROENTERITIS NOROVIRUS 1 0.0008
281 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 2 0.0008
282 LEARNING DISABILITY 4 0.0008
283 ANAESTHETIC COMPLICATION 2 0.0007
284 ENURESIS 3 0.0007
285 BLOOD SODIUM INCREASED 2 0.0007
286 ABDOMINAL RIGIDITY 2 0.0007
287 CALCULUS BLADDER 1 0.0007
288 IRRITABILITY 44 0.0007
289 CLONUS 2 0.0007
290 CORNEAL ABRASION 1 0.0007
291 INFUSION SITE RASH 1 0.0007
292 AUTISM SPECTRUM DISORDER 4 0.0007
293 COORDINATION ABNORMAL 10 0.0007
294 ANTICONVULSANT DRUG LEVEL DECREASED 1 0.0007
295 INTENSIVE CARE 1 0.0007
296 TREATMENT FAILURE 58 0.0007
297 CARDIAC VALVE DISEASE 4 0.0007
298 NOROVIRUS INFECTION 1 0.0007
299 VISUAL FIELD DEFECT 5 0.0007
300 NONINFECTIVE GINGIVITIS 1 0.0007
301 NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL 1 0.0007
302 URINE OUTPUT DECREASED 6 0.0007
303 ANGER 23 0.0007
304 NEPHRECTOMY 1 0.0007
305 GASTRITIS HAEMORRHAGIC 1 0.0007
306 ATYPICAL PNEUMONIA 2 0.0007
307 DRUG INTERACTION 106 0.0007
308 CENTRAL VENOUS CATHETERISATION 2 0.0007
309 PSYCHOMOTOR HYPERACTIVITY 11 0.0007
310 GINGIVAL HYPERTROPHY 1 0.0007
311 SELF INJURIOUS BEHAVIOUR 2 0.0007
312 PALLIATIVE CARE 1 0.0007
313 ENCEPHALOPATHY 16 0.0007
314 ORAL MUCOSAL ERUPTION 1 0.0007
315 PRODUCT DISTRIBUTION ISSUE 6 0.0006
316 COAGULATION TIME PROLONGED 1 0.0006
317 PSYCHOTIC DISORDER 19 0.0006
318 MEGACOLON 1 0.0006
319 RESPIRATORY RATE DECREASED 2 0.0006
320 INAPPROPRIATE AFFECT 1 0.0006
321 HALLUCINATION, AUDITORY 10 0.0006
322 SUSPECTED COVID-19 2 0.0006
323 EDUCATIONAL PROBLEM 1 0.0006
324 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 33 0.0006
325 DYSLIPIDAEMIA 3 0.0006
326 CHOREA 1 0.0006
327 BLOOD CHLORIDE INCREASED 1 0.0006
328 MEDICAL DEVICE REMOVAL 1 0.0006
329 HYPOPNOEA 2 0.0006
330 HOSPITALISATION 88 0.0006
331 MASTECTOMY 1 0.0006
332 AGITATION 42 0.0006
333 CATATONIA 3 0.0006
334 BRONCHIOLITIS 2 0.0006
335 LOGORRHOEA 2 0.0006
336 PANCREATIC FAILURE 1 0.0006
337 MITRAL VALVE DISEASE 1 0.0006
338 PRODUCT CONTAMINATION 2 0.0006
339 GASTROINTESTINAL MOTILITY DISORDER 3 0.0006
340 JOINT ARTHROPLASTY 1 0.0006
341 BRUXISM 3 0.0006
342 FACIAL BONES FRACTURE 2 0.0006
343 HIP SURGERY 3 0.0006
344 HYPOPHAGIA 14 0.0005
345 DISORGANISED SPEECH 1 0.0005
346 GRAND MAL CONVULSION 5 0.0005
347 DENTAL CARE 1 0.0005
348 FEELING DRUNK 4 0.0005
349 BLOOD IRON INCREASED 1 0.0005
350 IMPULSIVE BEHAVIOUR 2 0.0005
351 SNORING 2 0.0005
352 CATHETER SITE INFECTION 2 0.0005
353 VENTRICULAR SEPTAL DEFECT 3 0.0005
354 ACIDOSIS 4 0.0005
355 CRYING 19 0.0005
356 CLAVICLE FRACTURE 2 0.0005
357 ACUTE RESPIRATORY FAILURE 10 0.0005
358 IMPAIRED GASTRIC EMPTYING 7 0.0005
359 CONCOMITANT DISEASE PROGRESSION 1 0.0005
360 URINARY RETENTION 17 0.0005
361 GENE MUTATION 1 0.0005
362 CEREBRAL ATROPHY 2 0.0005
363 ABORTION SPONTANEOUS 20 0.0005
364 MUSCLE CONTRACTURE 1 0.0005
365 SMALL INTESTINAL OBSTRUCTION 6 0.0005
366 DRUG DIVERSION 3 0.0005
367 MOOD SWINGS 15 0.0005
368 ANAEMIA MACROCYTIC 1 0.0005
369 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 12 0.0005
370 RESPIRATORY FAILURE 34 0.0005
371 SKIN LACERATION 5 0.0005
372 IMMOBILE 2 0.0005
373 NEPHROLITHIASIS 21 0.0005
374 COLONOSCOPY 1 0.0005
375 GINGIVAL SWELLING 2 0.0005
376 INFECTIOUS MONONUCLEOSIS 1 0.0004
377 GASTROINTESTINAL HYPOMOTILITY 1 0.0004
378 REBOUND EFFECT 5 0.0004
379 VASCULAR DEVICE INFECTION 2 0.0004
380 EYE MOVEMENT DISORDER 3 0.0004
381 DENGUE FEVER 1 0.0004
382 METHAEMOGLOBINAEMIA 1 0.0004
383 FLAT AFFECT 1 0.0004
384 HYPERTRANSAMINASAEMIA 3 0.0004
385 VIRAL UPPER RESPIRATORY TRACT INFECTION 2 0.0004
386 EAR INFECTION 11 0.0004
387 HAEMATOLOGICAL INFECTION 1 0.0004
388 RENAL CELL CARCINOMA 2 0.0004
389 GLOMERULONEPHRITIS 1 0.0004
390 HYPOPHOSPHATAEMIA 3 0.0004
391 BREATH SOUNDS ABNORMAL 2 0.0004
392 DENTAL OPERATION 1 0.0004
393 STEVENS-JOHNSON SYNDROME 9 0.0004
394 GASTROINTESTINAL SOUNDS ABNORMAL 2 0.0004
395 SPEECH DISORDER 21 0.0004
396 FLUID INTAKE REDUCED 2 0.0004
397 PREGNANCY 8 0.0004
398 SECRETION DISCHARGE 5 0.0004
399 RESPIRATORY DISTRESS 11 0.0004
400 INTENTIONAL SELF-INJURY 8 0.0004
401 TOXIC EPIDERMAL NECROLYSIS 6 0.0004
402 INSURANCE ISSUE 6 0.0004
403 DECREASED APPETITE 91 0.0004
404 BOWEL MOVEMENT IRREGULARITY 3 0.0004
405 INITIAL INSOMNIA 4 0.0004
406 GAIT INABILITY 13 0.0004
407 DRUG TITRATION ERROR 1 0.0004
408 HERNIA REPAIR 1 0.0004
409 DIPLOPIA 10 0.0004
410 HEPATITIS TOXIC 1 0.0004
411 BRAIN FOG 6 0.0004
412 CONDITION AGGRAVATED 116 0.0004
413 INCONTINENCE 4 0.0004
414 AREFLEXIA 1 0.0004
415 BREAST SWELLING 1 0.0004
416 MYASTHENIA GRAVIS 3 0.0004
417 DECREASED ACTIVITY 4 0.0004
418 BALANCE DISORDER 32 0.0004
419 LIP BLISTER 1 0.0004
420 TIC 2 0.0004
421 CLUMSINESS 1 0.0004
422 BLOOD PHOSPHORUS INCREASED 1 0.0004
423 HICCUPS 3 0.0004
424 FAECALOMA 2 0.0004
425 INTESTINAL ISCHAEMIA 2 0.0004
426 DRUG LEVEL BELOW THERAPEUTIC 2 0.0004
427 TRANSAMINASES INCREASED 8 0.0004
428 STREPTOCOCCAL INFECTION 2 0.0004
429 EMOTIONAL DISORDER 11 0.0004
430 ENDOTRACHEAL INTUBATION 1 0.0004
431 DRUG TOLERANCE DECREASED 1 0.0004
432 INFUSION SITE ERYTHEMA 3 0.0004
433 EYE INFECTION 4 0.0004
434 PRESCRIBED UNDERDOSE 7 0.0004
435 PRODUCT CONTAINER ISSUE 3 0.0003
436 HYPERTONIA 2 0.0003
437 HYPOGLYCAEMIC COMA 1 0.0003
438 RESPIRATORY TRACT INFECTION 9 0.0003
439 ADENOVIRUS INFECTION 1 0.0003
440 SKIN WARM 2 0.0003
441 DEVICE POWER SOURCE ISSUE 1 0.0003
442 DYSSTASIA 10 0.0003
443 NECK INJURY 1 0.0003
444 URINE ODOUR ABNORMAL 2 0.0003
445 GROWTH RETARDATION 1 0.0003
446 PRODUCT USE IN UNAPPROVED INDICATION 84 0.0003
447 FEAR 9 0.0003
448 RESPIRATORY DISORDER 10 0.0003
449 DEVELOPMENTAL DELAY 3 0.0003
450 GASTROENTERITIS VIRAL 6 0.0003
451 MOOD ALTERED 9 0.0003
452 TENSION 2 0.0003
453 DYSCHEZIA 1 0.0003
454 MENTAL STATUS CHANGES 9 0.0003
455 DIASTOLIC DYSFUNCTION 1 0.0003
456 SCOLIOSIS 2 0.0003
457 OLIGURIA 2 0.0003
458 MIDDLE INSOMNIA 6 0.0003
459 ABORTION INDUCED 3 0.0003
460 HEAD INJURY 10 0.0003
461 THERAPEUTIC RESPONSE CHANGED 2 0.0003
462 EXPOSURE TO TOXIC AGENT 1 0.0003
463 MYDRIASIS 4 0.0003
464 WEIGHT DECREASED 87 0.0003
465 LOOSE TOOTH 1 0.0003
466 DRUG INEFFECTIVE 408 0.0003
467 DYSTONIA 6 0.0003
468 PRODUCT USE ISSUE 58 0.0003
469 LIVER ABSCESS 1 0.0003
470 BEDRIDDEN 4 0.0003
471 URINARY INCONTINENCE 9 0.0003
472 LISTLESS 1 0.0003
473 OXYGEN SATURATION DECREASED 17 0.0003
474 CORONAVIRUS INFECTION 2 0.0003
475 ANXIETY DISORDER 1 0.0003
476 BREAST MASS 2 0.0003
477 POSTOPERATIVE WOUND INFECTION 2 0.0003
478 FEEDING DISORDER 6 0.0003
479 PRODUCT TASTE ABNORMAL 4 0.0003
480 OFF LABEL USE 256 0.0003
481 RESPIRATORY ARREST 8 0.0003
482 BLOOD CREATININE ABNORMAL 1 0.0003
483 HANGOVER 1 0.0003
484 MACULOPATHY 1 0.0003
485 RETCHING 6 0.0003
486 APPENDICECTOMY 1 0.0003
487 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
488 COMPLICATION ASSOCIATED WITH DEVICE 4 0.0003
489 LIQUID PRODUCT PHYSICAL ISSUE 2 0.0003
490 TREATMENT NONCOMPLIANCE 15 0.0003
491 GASTROINTESTINAL PAIN 3 0.0003
492 TOOTH FRACTURE 3 0.0003
493 DYSKINESIA 11 0.0003
494 VIRAL INFECTION 9 0.0003
495 FALL 90 0.0003
496 URINARY TRACT INFECTION 46 0.0003
497 HYDRONEPHROSIS 2 0.0003
498 DYSARTHRIA 10 0.0003
499 INTENTIONAL OVERDOSE 17 0.0003
500 PRODUCT SUBSTITUTION ISSUE 15 0.0003
501 MUSCLE TWITCHING 6 0.0003
502 PNEUMONIA 84 0.0003
503 HYPOALBUMINAEMIA 2 0.0003
504 APNOEA 2 0.0003
505 EPIGASTRIC DISCOMFORT 1 0.0003
506 CYANOSIS 4 0.0003
507 RENAL CYST 2 0.0003
508 OBSESSIVE-COMPULSIVE DISORDER 2 0.0002
509 FRUSTRATION TOLERANCE DECREASED 2 0.0002
510 NO THERAPEUTIC RESPONSE 3 0.0002
511 POST PROCEDURAL INFECTION 2 0.0002
512 ABNORMAL FAECES 2 0.0002
513 ILEUS 3 0.0002
514 ERECTION INCREASED 1 0.0002
515 HYPERPYREXIA 1 0.0002
516 BUNDLE BRANCH BLOCK LEFT 1 0.0002
517 LUNG NEOPLASM 1 0.0002
518 INFUSION SITE PAIN 3 0.0002
519 ANURIA 2 0.0002
520 PARANOIA 4 0.0002
521 HORDEOLUM 1 0.0002
522 DELIRIUM 8 0.0002
523 PRODUCT DOSE OMISSION 15 0.0002
524 VOMITING 108 0.0002
525 NEUROTOXICITY 4 0.0002
526 DYSPHEMIA 1 0.0002
527 DEPRESSED MOOD 12 0.0002
528 SLEEP DISORDER 16 0.0002
529 RESPIRATORY RATE INCREASED 2 0.0002
530 PRODUCT DOSE OMISSION ISSUE 66 0.0002
531 QUALITY OF LIFE DECREASED 3 0.0002
532 ANAL INCONTINENCE 2 0.0002
533 SURGERY 13 0.0002
534 CHROMATURIA 5 0.0002
535 PRODUCT AVAILABILITY ISSUE 5 0.0002
536 DRUG LEVEL ABOVE THERAPEUTIC 1 0.0002
537 PNEUMONIA BACTERIAL 2 0.0002
538 EYE OPERATION 1 0.0002
539 PERSONALITY CHANGE 2 0.0002
540 LACERATION 2 0.0002
541 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 15 0.0002
542 NERVOUSNESS 11 0.0002
543 INCREASED APPETITE 4 0.0002
544 PULMONARY ARTERIAL HYPERTENSION 3 0.0002
545 INCORRECT DOSAGE ADMINISTERED 1 0.0002
546 GAIT DISTURBANCE 39 0.0002
547 HEPATOMEGALY 2 0.0002
548 BODY TEMPERATURE DECREASED 2 0.0002
549 HYPERNATRAEMIA 1 0.0002
550 ADVERSE DRUG REACTION 18 0.0002
551 LEUKOPENIA 10 0.0002
552 HYPOXIA 7 0.0002
553 APHASIA 6 0.0002
554 KLEBSIELLA INFECTION 1 0.0002
555 LYMPHADENOPATHY 7 0.0002
556 CONSTIPATION 43 0.0002
557 TASTE DISORDER 4 0.0002
558 BODY TEMPERATURE INCREASED 4 0.0002
559 FEMORAL NECK FRACTURE 1 0.0002
560 DEVICE RELATED INFECTION 3 0.0002
561 HELICOBACTER INFECTION 2 0.0002
562 ILLNESS 20 0.0002
563 FAILURE TO THRIVE 1 0.0002
564 THERAPY PARTIAL RESPONDER 3 0.0002
565 MATERNAL EXPOSURE DURING PREGNANCY 17 0.0002
566 WITHDRAWAL SYNDROME 8 0.0002
567 HALLUCINATION, VISUAL 4 0.0002
568 INFLUENZA 21 0.0002
569 EATING DISORDER 4 0.0002
570 PYREXIA 65 0.0002
571 DRUG DOSE OMISSION 31 0.0002
572 SENSORY DISTURBANCE 3 0.0002
573 DIARRHOEA 120 0.0002
574 GINGIVITIS 1 0.0002
575 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1 0.0002
576 PRODUCT PRESCRIBING ISSUE 4 0.0002
577 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
578 THERAPEUTIC RESPONSE DECREASED 11 0.0002
579 CYSTIC FIBROSIS 1 0.0002
580 INSOMNIA 48 0.0002
581 VENTRICULAR FIBRILLATION 2 0.0002
582 RASH MACULO-PAPULAR 4 0.0002
583 HEART RATE ABNORMAL 1 0.0002
584 INTERMENSTRUAL BLEEDING 1 0.0002
585 MALNUTRITION 2 0.0002
586 SKIN INFECTION 2 0.0002
587 MULTIPLE USE OF SINGLE-USE PRODUCT 1 0.0002
588 UNDERDOSE 13 0.0002
589 DISORIENTATION 7 0.0002
590 MICTURITION URGENCY 2 0.0002
591 NEOPLASM 2 0.0002
592 BLOOD URIC ACID INCREASED 1 0.0002
593 HYPERVENTILATION 1 0.0002
594 METABOLIC DISORDER 1 0.0002
595 COLD SWEAT 3 0.0002
596 ENERGY INCREASED 1 0.0002
597 PRODUCT PRESCRIBING ERROR 4 0.0002
598 BLOOD POTASSIUM DECREASED 5 0.0002
599 CONTUSION 16 0.0002
600 INJECTION SITE VESICLES 1 0.0002
601 WEIGHT INCREASED 37 0.0002
602 RESTLESSNESS 6 0.0002
603 SUICIDAL IDEATION 15 0.0002
604 RESPIRATORY DEPRESSION 2 0.0002
605 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
606 GENERALISED OEDEMA 2 0.0002
607 SEPSIS 18 0.0002
608 EXPOSURE DURING PREGNANCY 10 0.0002
609 SEPTIC SHOCK 7 0.0002
610 BACTERIAL INFECTION 3 0.0002
611 EPSTEIN-BARR VIRUS INFECTION 1 0.0002
612 BLOOD SODIUM DECREASED 3 0.0002
613 INFUSION SITE SWELLING 1 0.0002
614 BRAIN OEDEMA 2 0.0002
615 ACNE 12 0.0002
616 MUSCLE ATROPHY 2 0.0002
617 PROTEINURIA 3 0.0002
618 SLEEP APNOEA SYNDROME 3 0.0002
619 TREMOR 26 0.0002
620 INJURY 11 0.0002
621 POST PROCEDURAL COMPLICATION 3 0.0002
622 RASH GENERALISED 4 0.0002
623 HERPES SIMPLEX 1 0.0002
624 CHOKING 3 0.0002
625 PULMONARY CONGESTION 2 0.0002
626 STAPHYLOCOCCAL INFECTION 5 0.0002
627 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
628 SUICIDE ATTEMPT 9 0.0001
629 COLITIS ISCHAEMIC 1 0.0001
630 GENERAL PHYSICAL CONDITION ABNORMAL 1 0.0001
631 ALANINE AMINOTRANSFERASE INCREASED 9 0.0001
632 NEPHROTIC SYNDROME 1 0.0001
633 ECCHYMOSIS 1 0.0001
634 MEMORY IMPAIRMENT 20 0.0001
635 FATIGUE 111 0.0001
636 SEASONAL ALLERGY 2 0.0001
637 HAND FRACTURE 1 0.0001
638 INTENTIONAL DOSE OMISSION 4 0.0001
639 POOR QUALITY SLEEP 3 0.0001
640 DERMATITIS BULLOUS 1 0.0001
641 MENTAL DISORDER 6 0.0001
642 INTENTIONAL UNDERDOSE 1 0.0001
643 MOUTH HAEMORRHAGE 1 0.0001
644 TOXICITY TO VARIOUS AGENTS 23 0.0001
645 GAMMA-GLUTAMYLTRANSFERASE INCREASED 3 0.0001
646 GASTROINTESTINAL DISORDER 12 0.0001
647 THERAPEUTIC RESPONSE UNEXPECTED 6 0.0001
648 GENERAL SYMPTOM 1 0.0001
649 HEART RATE IRREGULAR 3 0.0001
650 HAEMODYNAMIC INSTABILITY 1 0.0001
651 DIZZINESS 65 0.0001
652 UPPER RESPIRATORY TRACT INFECTION 6 0.0001
653 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 1 0.0001
654 MULTIPLE ALLERGIES 1 0.0001
655 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
656 PRODUCT USE COMPLAINT 2 0.0001
657 FURUNCLE 1 0.0001
658 BLOOD ALBUMIN DECREASED 1 0.0001
659 RESPIRATORY TRACT CONGESTION 2 0.0001
660 ABSCESS 2 0.0001
661 TACHYCARDIA 11 0.0001
662 MENTAL IMPAIRMENT 3 0.0001
663 MUSCLE TIGHTNESS 2 0.0001
664 MANIA 2 0.0001
665 ESCHERICHIA INFECTION 1 0.0001
666 ABASIA 3 0.0001
667 VENTRICULAR TACHYCARDIA 2 0.0001
668 MENSTRUAL DISORDER 1 0.0001
669 COAGULOPATHY 2 0.0001
670 EOSINOPHIL COUNT INCREASED 1 0.0001
671 ATRIAL SEPTAL DEFECT 1 0.0001
672 ADVERSE EVENT 11 0.0001
673 NASOPHARYNGITIS 22 0.0001
674 RASH 52 0.0001
675 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 4 0.0001
676 SINUSITIS 12 0.0001
677 CARDIAC OPERATION 1 0.0001
678 UNRESPONSIVE TO STIMULI 3 0.0001
679 AMENORRHOEA 2 0.0001
680 ABDOMINAL DISCOMFORT 19 0.0001
681 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
682 CARDIOTOXICITY 1 0.0001
683 MOBILITY DECREASED 8 0.0001
684 WRONG TECHNIQUE IN DRUG USAGE PROCESS 4 0.0001
685 LIP DRY 1 0.0001
686 OPTIC NEURITIS 1 0.0001
687 SKIN LESION 3 0.0001
688 CARDIAC ARREST 9 0.0001
689 BRAIN NEOPLASM 1 0.0001
690 SKIN DISCOLOURATION 5 0.0001
691 INCREASED TENDENCY TO BRUISE 1 0.0001
692 DYSURIA 4 0.0001
693 IRON DEFICIENCY ANAEMIA 1 0.0001
694 HYPOKALAEMIA 5 0.0001
695 CONJUNCTIVITIS 2 0.0001
696 ERYTHEMA MULTIFORME 1 0.0001
697 PRODUCT DOSE OMISSION IN ERROR 3 0.0001
698 FLATULENCE 6 0.0001
699 FRACTURE 2 0.0001
700 FOOT FRACTURE 2 0.0001
701 DYSPHAGIA 10 0.0001
702 DISEASE RECURRENCE 5 0.0001
703 DEHYDRATION 14 0.0001
704 RASH ERYTHEMATOUS 5 0.0001
705 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
706 AFFECT LABILITY 1 0.0001
707 INFECTION 15 0.0001
708 HYPERCHOLESTEROLAEMIA 1 0.0001
709 DRUG INTOLERANCE 10 0.0001
710 ATELECTASIS 1 0.0001
711 EAR PAIN 2 0.0001
712 INTENTIONAL PRODUCT MISUSE 9 0.0001
713 ORAL HERPES 2 0.0001
714 NASAL CONGESTION 6 0.0001
715 HOSPICE CARE 1 0.0001
716 LIGAMENT SPRAIN 1 0.0001
717 DEPRESSED LEVEL OF CONSCIOUSNESS 4 0.0001
718 ASTHENIA 38 0.0001
719 HEART RATE INCREASED 10 0.0001
720 BLADDER DISORDER 1 0.0001
721 UPPER LIMB FRACTURE 2 0.0001
722 OVARIAN CYST 1 0.0001
723 BRAIN INJURY 1 0.0001
724 HYPOTHERMIA 1 0.0001
725 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1 0.0001
726 COVID-19 17 0.0001
727 FEMUR FRACTURE 3 0.0001
728 COUGH 27 0.0001
729 PULMONARY HYPERTENSION 2 0.0001
730 POLLAKIURIA 4 0.0001
731 MOUTH ULCERATION 2 0.0001
732 ANXIETY 27 0.0001
733 DRUG ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
734 JOINT DISLOCATION 1 0.0001
735 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
736 ASPARTATE AMINOTRANSFERASE INCREASED 5 0.0001
737 METABOLIC ACIDOSIS 3 0.0001
738 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 19 0.0001
739 MOVEMENT DISORDER 3 0.0001
740 HYPOACUSIS 4 0.0001
741 CONFUSIONAL STATE 15 0.0001
742 MENSTRUATION DELAYED 1 0.0001
743 BIPOLAR DISORDER 1 0.0001
744 BLOOD CREATININE INCREASED 6 0.0001
745 OESOPHAGITIS 1 0.0001
746 DEATH 78 0.0001
747 FOOT DEFORMITY 1 0.0001
748 FUNGAL INFECTION 3 0.0001
749 TOOTH DISORDER 2 0.0001
750 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
751 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
752 SNEEZING 2 0.0001
753 INTESTINAL PERFORATION 1 0.0001
754 PANCREATITIS ACUTE 2 0.0001
755 BLOOD CALCIUM DECREASED 1 0.0001
756 HEPATIC ENZYME INCREASED 6 0.0001
757 DERMATITIS CONTACT 1 0.0001
758 GASTROOESOPHAGEAL REFLUX DISEASE 7 0.0001
759 GASTRIC HAEMORRHAGE 1 0.0001
760 ELECTROLYTE IMBALANCE 1 0.0001
761 HEART RATE DECREASED 3 0.0001
762 COVID-19 PNEUMONIA 1 0.0001
763 THERAPY INTERRUPTED 6 0.0001
764 MACULAR DEGENERATION 1 0.0001
765 MUSCLE RIGIDITY 1 0.0001
766 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 4 0.0001
767 DISCOMFORT 5 0.0001
768 MUSCLE SPASTICITY 1 0.0001
769 CARDIOMEGALY 1 0.0001
770 VISUAL IMPAIRMENT 10 0.0001
771 CYST 1 0.0001
772 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
773 PEMPHIGUS 1 0.0001
774 HALLUCINATION 6 0.0001
775 MUSCULAR WEAKNESS 9 0.0001
776 COLITIS 3 0.0001
777 DEPRESSION 18 0.0001
778 PRODUCT COMPLAINT 2 0.0001
779 HEPATITIS 2 0.0001
780 PERIPHERAL SWELLING 12 0.0001
781 HIATUS HERNIA 1 0.0001
782 GASTRITIS 2 0.0001
783 ORAL CANDIDIASIS 1 0.0001
784 ADVERSE REACTION 1 0.0001
785 HAIR TEXTURE ABNORMAL 1 0.0001
786 DISTURBANCE IN ATTENTION 4 0.0001
787 EXTRA DOSE ADMINISTERED 3 0.0001
788 AKATHISIA 1 0.0001
789 GINGIVAL BLEEDING 1 0.0001
790 NAUSEA 57 0.0001
791 WOUND 2 0.0001
792 BLISTER 4 0.0001
793 BLOOD TEST ABNORMAL 1 0.0001
794 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
795 HYPONATRAEMIA 4 0.0001
796 BLINDNESS UNILATERAL 1 0.0001
797 LYMPHOPENIA 1 0.0001
798 DIALYSIS 1 0.0001
799 PARALYSIS 1 0.0001
800 CARDIOGENIC SHOCK 1 0.0001
801 PARAESTHESIA ORAL 1 0.0001
802 HYPOKINESIA 1 0.0001
803 LIVER FUNCTION TEST ABNORMAL 2 0.0001
804 APATHY 1 0.0001
805 GASTROENTERITIS 1 0.0001
806 ABDOMINAL PAIN UPPER 14 0.0001
807 ANGIOEDEMA 3 0.0001
808 CARDIOMYOPATHY 1 0.0001
809 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
810 IMMUNODEFICIENCY 1 0.0001
811 HAEMORRHAGE INTRACRANIAL 1 0.0001
812 EPISTAXIS 5 0.0001
813 PRODUCT QUALITY ISSUE 9 0.0001
814 ALOPECIA 13 0.0001
815 BLOOD COUNT ABNORMAL 1 0.0001
816 VERTIGO 4 0.0001
817 MUSCLE SPASMS 12 0.0001
818 OROPHARYNGEAL PAIN 6 0.0001
819 DELUSION 1 0.0001
820 BLOOD CHOLESTEROL INCREASED 3 0.0001
821 EJECTION FRACTION DECREASED 1 0.0001
822 FEELING ABNORMAL 15 0.0001
823 THROMBOCYTOPENIA 7 0.0001
824 HIP FRACTURE 2 0.0001
825 RHINORRHOEA 4 0.0001
826 LACTIC ACIDOSIS 2 0.0001
827 BLOOD POTASSIUM INCREASED 1 0.0001
828 AMNESIA 4 0.0001
829 DYSPEPSIA 6 0.0001
830 LIP SWELLING 2 0.0001
831 SKIN DISORDER 2 0.0001
832 BLOOD UREA INCREASED 1 0.0001
833 FACE OEDEMA 1 0.0001
834 CANDIDA INFECTION 1 0.0001
835 HEMIPARESIS 1 0.0001
836 THERAPY CESSATION 3 0.0001
837 MULTI-ORGAN FAILURE 1 0.0001
838 NIGHTMARE 2 0.0001
839 ABDOMINAL DISTENSION 6 0.0001
840 ORTHOSTATIC HYPOTENSION 1 0.0001
841 LOCAL SWELLING 1 0.0001
842 RASH MACULAR 2 0.0001
843 EOSINOPHILIA 1 0.0001
844 PANCREATITIS 3 0.0001
845 BRADYCARDIA 3 0.0001
846 HEAD DISCOMFORT 1 0.0001
847 DRUG ERUPTION 1 0.0001
848 CEREBRAL HAEMORRHAGE 2 0.0001
849 DRUG EFFECT DECREASED 3 0.0001
850 OEDEMA 3 0.0001
851 MALAISE 24 0.0001
852 HYPERSENSITIVITY 10 0.0001
853 AGRANULOCYTOSIS 1 0.0001
854 SWELLING 5 0.0001
855 DYSPNOEA EXERTIONAL 2 0.0001
856 HEADACHE 33 0.0001
857 ANAEMIA 10 0.0001
858 DRUG PRESCRIBING ERROR 1 0.0001
859 HERNIA 1 0.0001
860 DISABILITY 1 0.0001
861 BLOOD PRESSURE ABNORMAL 1 0.0001
862 NO ADVERSE EVENT 9 0.0000
863 NEUTROPHIL COUNT DECREASED 2 0.0000
864 OSTEOPOROSIS 2 0.0000
865 RHABDOMYOLYSIS 2 0.0000
866 ROAD TRAFFIC ACCIDENT 2 0.0000
867 KNEE ARTHROPLASTY 1 0.0000
868 RENAL FAILURE ACUTE 2 0.0000
869 LOSS OF CONSCIOUSNESS 6 0.0000
870 JOINT INJURY 1 0.0000
871 LIVER FUNCTION TEST INCREASED 1 0.0000
872 RECTAL HAEMORRHAGE 2 0.0000
873 OVERDOSE 10 0.0000
874 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
875 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
876 MUSCULOSKELETAL STIFFNESS 4 0.0000
877 BLOOD PRESSURE DECREASED 3 0.0000
878 LIVER DISORDER 2 0.0000
879 COLITIS ULCERATIVE 2 0.0000
880 THROAT IRRITATION 2 0.0000
881 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 8 0.0000
882 APPLICATION SITE PRURITUS 1 0.0000
883 INCORRECT DOSE ADMINISTERED 10 0.0000
884 VISION BLURRED 6 0.0000
885 GENERAL PHYSICAL HEALTH DETERIORATION 5 0.0000
886 RENAL DISORDER 2 0.0000
887 DEVICE MALFUNCTION 3 0.0000
888 ARRHYTHMIA 2 0.0000
889 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 3 0.0000
890 BLOOD PRESSURE FLUCTUATION 1 0.0000
891 JOINT SWELLING 5 0.0000
892 HYPOGLYCAEMIA 2 0.0000
893 OEDEMA PERIPHERAL 5 0.0000
894 LIVER INJURY 1 0.0000
895 HYPOTENSION 8 0.0000
896 CELLULITIS 2 0.0000
897 UNEVALUABLE EVENT 3 0.0000
898 HAEMATEMESIS 1 0.0000
899 ERYTHEMA 8 0.0000
900 HAEMORRHAGE 4 0.0000
901 DEAFNESS 1 0.0000
902 ECZEMA 2 0.0000
903 PLATELET COUNT DECREASED 4 0.0000
904 NEUTROPENIA 5 0.0000
905 DEVICE DELIVERY SYSTEM ISSUE 1 0.0000
906 INFLUENZA LIKE ILLNESS 3 0.0000
907 COMPLETED SUICIDE 3 0.0000
908 MEDICATION ERROR 2 0.0000
909 NECK PAIN 2 0.0000
910 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
911 EYE IRRITATION 2 0.0000
912 ABDOMINAL PAIN 8 0.0000
913 LABORATORY TEST ABNORMAL 1 0.0000
914 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
915 CORONARY ARTERY DISEASE 1 0.0000
916 STOMATITIS 2 0.0000
917 ILL-DEFINED DISORDER 2 0.0000
918 ACUTE KIDNEY INJURY 5 0.0000
919 DRUG ADMINISTRATION ERROR 1 0.0000
920 LIMB DISCOMFORT 1 0.0000
921 CARDIAC DISORDER 3 0.0000
922 NERVOUS SYSTEM DISORDER 1 0.0000
923 DRUG-INDUCED LIVER INJURY 1 0.0000
924 MIGRAINE 3 0.0000
925 HYPOTHYROIDISM 1 0.0000
926 SWELLING FACE 2 0.0000
927 EYE DISORDER 1 0.0000
928 INFUSION RELATED REACTION 2 0.0000
929 EXPIRED PRODUCT ADMINISTERED 1 0.0000
930 FLUSHING 3 0.0000
931 PAIN 18 0.0000
932 HAEMATURIA 1 0.0000
933 NEOPLASM PROGRESSION 1 0.0000
934 HYPERKALAEMIA 1 0.0000
935 HYPERTENSION 6 0.0000
936 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
937 DRUG EFFECT INCOMPLETE 1 0.0000
938 ACCIDENTAL OVERDOSE 1 0.0000
939 DYSGEUSIA 2 0.0000
940 EYE SWELLING 1 0.0000
941 HEPATIC FUNCTION ABNORMAL 1 0.0000
942 PRURITUS 10 0.0000
943 DISEASE PROGRESSION 3 0.0000
944 CARDIAC FAILURE 2 0.0000
945 DRY MOUTH 2 0.0000
946 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
947 CARDIO-RESPIRATORY ARREST 1 0.0000
948 URTICARIA 4 0.0000
949 HYPERHIDROSIS 3 0.0000
950 DEVICE DISLOCATION 1 0.0000
951 PRODUCT STORAGE ERROR 2 0.0000
952 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
953 DRUG WITHDRAWAL SYNDROME 2 0.0000
954 DRY SKIN 3 0.0000
955 DEVICE ISSUE 2 0.0000
956 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
957 NEUROPATHY PERIPHERAL 2 0.0000
958 COMA 1 0.0000
959 BLOOD GLUCOSE DECREASED 1 0.0000
960 DRY EYE 1 0.0000
961 FLUID RETENTION 1 0.0000
962 BLOOD PRESSURE INCREASED 3 0.0000
963 HAEMOGLOBIN DECREASED 2 0.0000
964 DYSPNOEA 11 0.0000
965 INFLAMMATION 1 0.0000
966 MUSCULOSKELETAL PAIN 1 0.0000
967 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
968 HAEMATOCHEZIA 1 0.0000
969 ARTHROPATHY 1 0.0000
970 ASTHMA 2 0.0000
971 HERPES ZOSTER 1 0.0000
972 BACK PAIN 4 0.0000
973 CHILLS 2 0.0000
974 PAIN IN EXTREMITY 5 0.0000
975 CATARACT 1 0.0000
976 EMOTIONAL DISTRESS 2 0.0000
977 FEELING HOT 1 0.0000
978 BURNING SENSATION 1 0.0000
979 BRONCHITIS 1 0.0000
980 HOT FLUSH 1 0.0000
981 PARAESTHESIA 2 0.0000
982 INJECTION SITE BRUISING 1 0.0000
983 CARDIAC FAILURE CONGESTIVE 1 0.0000
984 DRUG DEPENDENCE 2 0.0000
985 CEREBROVASCULAR ACCIDENT 2 0.0000
986 MYOCARDIAL INFARCTION 2 0.0000
987 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
988 PALPITATIONS 1 0.0000
989 ARTHRALGIA 3 0.0000
990 HYPOAESTHESIA 1 0.0000
991 INJECTION SITE PAIN 2 0.0000
992 MYALGIA 1 0.0000
993 BLOOD GLUCOSE INCREASED 1 0.0000